MET and cancer: Some of its well-known targets include genes like BCL2 (B-cell lymphoma 2), MET (hepatocyte growth factor receptor), and MYC (proto-oncogene) and it is regulated by the tumor suppressor protein p53, which is often mutated in various cancers [150].